RYAHX
Price
$139.53
Change
+$0.96 (+0.69%)
Updated
Dec 4 closing price
Net Assets
12.63M
RYVYX
Price
$736.23
Change
-$1.54 (-0.21%)
Updated
Dec 4 closing price
Net Assets
1.57B
Interact to see
Advertisement

RYAHX vs RYVYX

Header iconRYAHX vs RYVYX Comparison
Open Charts RYAHX vs RYVYXBanner chart's image
Rydex Mid-Cap 1.5x Strategy A
Price$139.53
Change+$0.96 (+0.69%)
VolumeN/A
Net Assets12.63M
Rydex NASDAQ-100® 2x Strategy H
Price$736.23
Change-$1.54 (-0.21%)
VolumeN/A
Net Assets1.57B
RYAHX vs RYVYX Comparison Chart in %
View a ticker or compare two or three
VS
RYAHX vs. RYVYX commentary
Dec 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYAHX is a Buy and RYVYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.57B vs. RYAHX (12.6M). RYAHX pays higher dividends than RYVYX: RYAHX (0.69) vs RYVYX (0.00). RYAHX was incepted earlier than RYVYX: RYAHX (22 years) vs RYVYX (26 years). RYVYX (1.87) and RYAHX (1.79) have similar cost to investors . RYVYX is a more actively managed with annual turnover of: 383.00 vs. RYAHX (94.00). RYAHX (2500) and RYVYX (2500) have matching initial minimum investment requirements. RYVYX annual gain was more profitable for investors over the last year : 20.43 vs. RYAHX (-5.11). RYVYX return over 5 years is better than : 114.77 vs. RYAHX (33.20).
RYAHXRYVYXRYAHX / RYVYX
Total Expense Ratio1.671.7496%
Annual Report Gross Expense Ratio1.791.8796%
Fund Existence22 years26 years-
Gain YTD6.09033.76818%
Front Load5%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets12.6M1.57B1%
Annual Yield % from dividends0.690.00-
Returns for 1 year-5.1120.43-25%
Returns for 3 years38.90232.2517%
Returns for 5 years33.20114.7729%
Returns for 10 years133.16770.2317%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPX5.540.26
+4.92%
Compass Therapeutics
PAY36.501.66
+4.76%
Paymentus Holdings
EW85.781.80
+2.14%
Edwards Lifesciences Corp
BGI1.090.01
+1.05%
Birks Group
CXDO6.71-0.04
-0.59%
Crexendo